Panel Title: Minimizing the Ripple Effect of FDA and FTC Enforcement Actions: How to Mitigate Downstream Litigation Exposure to “Me-Too” and Follow-On Class Action Litigation Created by FDA Warning Letters, FTC Actions and On-Site Inspections – What to Do, When and How
Attendees will learn:
- what types of behavior can trigger negative attention from the government;
- how to respond to government warning letters without creating a litigation roadmap;
- how to deal with adverse publicity, particularly when government claims are cast using “fraud” language or arise as the direct result of government action; and
- ensuring appropriate corrective action is taken when a food safety or product advertising/labeling issue is identified.
Claudia Lewis-Eng, Esq., Partner, Venable LLP
For more information and to register, click here.